Health-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational Study
NCT05294289
·
clinicaltrials.gov ↗
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class
Conditions
PIK3CA-related Overgrowth Spectrum
Interventions
OTHER:
Alpelisib
Sponsor
Novartis Pharmaceuticals